News

US President Trump has signed executive orders to speed up drug approvals and pharma infrastructure construction in the US ...
Round co-led by new investors, Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio, and Boehringer Ingelheim Venture Fund ...